Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
Note: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2024 Division of Allergy, Immunology, and Transplantation (DAIT) Concept
FY 2025 DAIT Concepts
- Computational Models of Influenza Immunity
- Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs)
- Fc-Dependent Mechanisms of Antibody-Mediated Killing
- RNCP Portfolio-Wide Dosimetry Verification Services
- Notice of Special Interest (NOSI)—Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms
- Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts
- Notice of Special Interest (NOSI)—Understanding the Immune Functions of DEAD/H-box Helicases
Notice of Special Interest (NOSI)—Research on Early Allergy Determinants Using Biosamples from the SUNBEAM Birth Cohort
For the published notice of special interest, check the July 25, 2023 Guide notice, Notice of Special Interest (NOSI): Research on Early Allergy Determinants using Biosamples from the SUNBEAM Birth Cohort.
Computational Models of Influenza Immunity
For the published request for applications, check the September 13, 2023 Guide announcement, Computational Models of Influenza Immunity (U01, Clinical Trial Not Allowed).
Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs)
For the published request for applications, check the October 24, 2023 Guide announcement, Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01, Clinical Trial Not Allowed).
Fc-Dependent Mechanisms of Antibody-Mediated Killing
For the published request for applications, check the September 26, 2023 Guide announcement, Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01, Clinical Trial Not Allowed).
RNCP Portfolio-Wide Dosimetry Verification Services
For the published request for proposals, check the January 5, 2024 solicitation, RNCP Portfolio-Wide Dosimetry Verification Services.
Notice of Special Interest (NOSI)—Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms
For the published notice of special interest, check the July 12, 2024 Guide notice, Notice of Special Interest (NOSI) Using the Collaborative Cross (CC) Mouse Model for Immunoregulatory and Infectious Disease Research.
Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts
For the published notice of special interest, check the July 18, 2024 Guide notice, Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts.
Notice of Special Interest (NOSI)—Understanding the Immune Functions of DEAD/H-box Helicases
For the published notice of special interest, check the July 22, 2024 Guide notice, Notice of Special Interest (NOSI): Understanding the Immune Functions of DEAD/H-box Helicases.